Naokazu Nakamura

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Optimizing activation and culture conditions for the production of cord blood-derived CAR-T and natural killer cells.

Optimizing activation and culture conditions for the production of cord blood-derived CAR-T and natural killer cells.

Journal: British journal of haematology

Published: May 04, 2025

Increased relative eosinophil counts portend neck oedema after chimeric antigen receptor-T therapy.

Increased relative eosinophil counts portend neck oedema after chimeric antigen receptor-T therapy.

Journal: British journal of haematology

Published: December 08, 2024

Comparison of methotrexate dosing protocols for graft-versus-host disease prophylaxis after unrelated hematopoietic stem cell transplantation.

Comparison of methotrexate dosing protocols for graft-versus-host disease prophylaxis after unrelated hematopoietic stem cell transplantation.

Journal: Cytotherapy

Published: October 02, 2024

Fluctuation of physical function during chimeric antigen receptor T-cell therapy during rehabilitation intervention: Real-world data and risk factor analyses.

Fluctuation of physical function during chimeric antigen receptor T-cell therapy during rehabilitation intervention: Real-world data and risk factor analyses.

Journal: EJHaem

Published: August 12, 2024

Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen T-cell (CAR-T) therapy.

Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen T-cell (CAR-T) therapy.

Journal: Oxford medical case reports

Published: July 16, 2024

Pathogenic TNFRSF13B Variant in an Adult Japanese Patient with Common Variable Immunodeficiency.

Pathogenic TNFRSF13B Variant in an Adult Japanese Patient with Common Variable Immunodeficiency.

Journal: Internal medicine (Tokyo, Japan)

Published: July 10, 2024

COVID-19 antibody titers after tixagevimab-cilgavimab injection in patients with hematologic diseases; a single-center, prospective study.

COVID-19 antibody titers after tixagevimab-cilgavimab injection in patients with hematologic diseases; a single-center, prospective study.

Journal: Leukemia & lymphoma

Published: April 16, 2024

Red blood cell distribution width is a useful biomarker to predict bleeding and thrombosis risks in patients with immune thrombocytopenic purpura.

Red blood cell distribution width is a useful biomarker to predict bleeding and thrombosis risks in patients with immune thrombocytopenic purpura.

Journal: EJHaem

Published: March 27, 2024

Recurrence of solitary plasmacytoma in the liver 10 years after the onset of multiple bone lesions.

Recurrence of solitary plasmacytoma in the liver 10 years after the onset of multiple bone lesions.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 27, 2024

Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.

Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.

Journal: Clinical and experimental medicine

Published: March 18, 2024

Severe consciousness disturbance after cord blood transplantation for relapsed T lymphoblastic lymphoma

Severe consciousness disturbance after cord blood transplantation for relapsed T lymphoblastic lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 04, 2024

Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome.

Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome.

Journal: International journal of hematology

Published: December 06, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026